Status:
COMPLETED
Effect of Metformin in Patients With Type-1 Diabetes With Inadequate Glycaemic Control by Insulin and Diet
Lead Sponsor:
Steno Diabetes Center Copenhagen
Conditions:
Diabetes Mellitus, Type 1
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Ninety percent of patients with type-1-diabetes will develop late-diabetic complications in the eyes, kidneys, nervous- or cardiovascular-system. Poor glycaemic control is an important risk-factor for...
Eligibility Criteria
Inclusion
- HbA1c \> 8.5% for more than one year prior to enrolment.
- Diabetes-duration \> 5 years.
- Age at onset of diabetes \< 35 years
- Fasting C-peptide \< 300 pmol/l
- Age \> 18 years at enrolment.
Exclusion
- Clinical or biochemical signs of kidney-, liver- or heart-failure.
- Other coexisting serious morbidity, which will affect the study-participation or outcome of the study i.e. cancer.
- Known abuse of any medication or alcohol
- Hypoglycaemia unawareness.
- Pregnancy or planned pregnancy in the study-period.
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2006
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00118937
Start Date
December 1 2003
End Date
August 1 2006
Last Update
December 8 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.